ObamaCare Is All About Rationing: Difference between revisions

From Discourse DB
Jump to navigation Jump to search
(Created page with '{{Item |author=Martin Feldstein |source=The Wall Street Journal |date=August 18, 2009 |url=http://online.wsj.com/article/SB10001424052970204683204574358233780260914.html |quote="...')
 
m (Text replace - 'America's Affordable Health Choices Act of 2009' to 'Patient Protection and Affordable Care Act')
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:
|date=August 18, 2009
|date=August 18, 2009
|url=http://online.wsj.com/article/SB10001424052970204683204574358233780260914.html
|url=http://online.wsj.com/article/SB10001424052970204683204574358233780260914.html
|quote="In the British national health service, a government agency approves only those expensive treatments that add at least one Quality Adjusted Life Year (QALY) per £30,000 (about $49,685) of additional health-care spending. If a treatment costs more per QALY, the health service will not pay for it. The existence of such a program in the United States would not only deny lifesaving care but would also cast a pall over medical researchers who would fear that government experts might reject their discoveries as "too expensive.""
|quote="In the British national health service, a government agency approves only those expensive treatments that add at least one Quality Adjusted Life Year (QALY) per £30,000 (about $49,685) of additional health-care spending. If a treatment costs more per QALY, the health service will not pay for it. The existence of such a program in the United States would not only deny lifesaving care but would also cast a pall over medical researchers who would fear that government experts might reject their discoveries as "too expensive."
}}
}}
{{Opinion|America's Affordable Health Choices Act of 2009|Act should be passed|against}}
{{Opinion|Patient Protection and Affordable Care Act|Act should be passed|against}}

Latest revision as of 14:37, March 11, 2010

This is an opinion item.

Author(s) Martin Feldstein
Source The Wall Street Journal
Date August 18, 2009
URL http://online.wsj.com/article/SB10001424052970204683204574358233780260914.html
Quote
Quotes-start.png "In the British national health service, a government agency approves only those expensive treatments that add at least one Quality Adjusted Life Year (QALY) per £30,000 (about $49,685) of additional health-care spending. If a treatment costs more per QALY, the health service will not pay for it. The existence of such a program in the United States would not only deny lifesaving care but would also cast a pall over medical researchers who would fear that government experts might reject their discoveries as "too expensive." Quotes-end.png


Add or change this opinion item's references


This item argues against the position Act should be passed on the topic Patient Protection and Affordable Care Act.